These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6893865)

  • 1. The BEIR III controversy.
    Fabrikant JI
    Radiat Res; 1980 Dec; 84(3):361-8. PubMed ID: 6893865
    [No Abstract]   [Full Text] [Related]  

  • 2. Human health effects of low doses of ionizing radiation: the BEIR III controversy.
    Radford EP
    Radiat Res; 1980 Dec; 84(3):369-94. PubMed ID: 6893866
    [No Abstract]   [Full Text] [Related]  

  • 3. Comments on the somatic effects section of the BEIR III report.
    Rossi HH
    Radiat Res; 1980 Dec; 84(3):395-406. PubMed ID: 6893867
    [No Abstract]   [Full Text] [Related]  

  • 4. The BEIR-III Report: origin of the controversy.
    Fabrikant JI
    AJR Am J Roentgenol; 1981 Jan; 136(1):209-14. PubMed ID: 6779574
    [No Abstract]   [Full Text] [Related]  

  • 5. BEIR V report. Experts urge cautious interpretation of higher risk estimates.
    Tilyou SM
    J Nucl Med; 1990 Apr; 31(4):13A-19A. PubMed ID: 2324815
    [No Abstract]   [Full Text] [Related]  

  • 6. Panel review: a review of past risk assessments and extrapolation problems with radiation.
    Eisenbud M; Burns F; Jones WB; Cohen B
    J Environ Pathol Toxicol; 1980 Mar; 3(4 Spec No):419-30. PubMed ID: 7391735
    [No Abstract]   [Full Text] [Related]  

  • 7. [Ionizing radiation. Health effects of low doses].
    Tubiana M
    Rev Epidemiol Sante Publique; 1982; 30(2):131-49. PubMed ID: 7134563
    [No Abstract]   [Full Text] [Related]  

  • 8. Incorporating information from the U.S. Department of Energy low-dose program into regulatory decision-making: three policy integration challenges.
    Locke PA
    Health Phys; 2009 Nov; 97(5):510-5. PubMed ID: 19820461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. U.S. science policy. Obama courts a smitten audience at the national academy.
    Mervis J
    Science; 2009 May; 324(5927):576-7. PubMed ID: 19407168
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of low level radiation-what's new?
    Royal HD
    Semin Nucl Med; 2008 Sep; 38(5):392-402. PubMed ID: 18662560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Science policy. Report faults U.S. strategy for nanotoxicology research.
    Service RF
    Science; 2008 Dec; 322(5909):1779. PubMed ID: 19095914
    [No Abstract]   [Full Text] [Related]  

  • 12. Impact and misuse of BEIR V.
    Vetter RJ
    Health Phys; 1990 May; 58(5):557-8. PubMed ID: 2341245
    [No Abstract]   [Full Text] [Related]  

  • 13. Report of National Cancer Institute symposium: comparison of mechanisms of carcinogenesis by radiation and chemical agents. I. Common molecular mechanisms.
    Borg DC
    Basic Life Sci; 1985; 33():17-42. PubMed ID: 4015581
    [No Abstract]   [Full Text] [Related]  

  • 14. Key studies used to support cancer risk assessment questioned.
    Calabrese EJ
    Environ Mol Mutagen; 2011 Oct; 52(8):595-606. PubMed ID: 21786337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. National Academy of Sciences enters controversy on relevance of animal toxicologic studies.
    Environ Health Perspect; 1993 Apr; 101(1):19. PubMed ID: 8513757
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic and policy considerations drive the LNT debate.
    Mossman KL
    Radiat Res; 2008 Feb; 169(2):245; author reply 246-7. PubMed ID: 18220464
    [No Abstract]   [Full Text] [Related]  

  • 17. U.S. national academies. Advice on science advising leaves plenty of questions.
    Mervis J
    Science; 2004 Nov; 306(5701):1450-1. PubMed ID: 15567817
    [No Abstract]   [Full Text] [Related]  

  • 18. The debate on the use of linear no threshold for assessing the effects of low doses.
    Tubiana M; Aurengo A; Averbeck D; Masse R
    J Radiol Prot; 2006 Sep; 26(3):317-24. PubMed ID: 16926474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An abuse of risk assessment: how regulatory agencies improperly adopted LNT for cancer risk assessment.
    Calabrese EJ
    Arch Toxicol; 2015 Apr; 89(4):647-8. PubMed ID: 25596944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk characterization: A bridge to informed decision making.
    North DW
    Fundam Appl Toxicol; 1997 Oct; 39(2):81-8. PubMed ID: 9344620
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.